Granular cell tumor of the sellar and suprasellar region

Clinicopathologic study of 11 cases and literature review

Aaron A. Cohen-Gadol, Mark A. Pichelmann, Michael J. Link, Bernd W. Scheithauer, Karl N. Krecke, William Francis Young, Jules Hardy, Caterina Giannini

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objective: To report a series of cases of surgically resected granular cell tumors in an attempt to better characterize their clinical presentation, imaging features, and treatment outcomes with attention to previously published literature. Patients and Methods: This is a retrospective study of 11 patients with granular cell tumors. Information obtained from patients' medical records was supplemented by direct physician and patient telephone contact. Results: The study group consisted of 9 women and 2 men, with a mean ± SD age of 50±15 years (range, 26-73 years). Seven patients were symptomatic, 3 of whom presented with visual complaints. Four patients presented primarily with endocrine dysfunction (2) or headaches (2). The duration of symptoms varied from 1 to 12 months (mean ± SD, 6.0±4.5 months). Formal visual field testing revealed bitemporal hemianopsia in 6 and a right-sided visual field deficit in 2. The tumor appeared as a welldefined, relatively homogeneously (6) or heterogeneously (1) enhancing suprasellar mass on contrast infusion. Tumor size varied from 1.5 to 6.0 cm (mean ± SD, 3.1±1.6 cm). At surgery, the mass was noted to be firm and vascular, and in at least 3 patients these features prevented gross total resection. Only 1 patient who had undergone biopsy of his lesion received adjuvant radiation therapy. Followup was obtained in all but 1 patient. Nine of these 10 patients are alive and are either free of disease or have had no disease progression. Follow-up in these 9 patients varied from 1 to 16 years (mean ± SD, 6.5±5.3 years). Conclusions: A granular cell tumor is generally a surprise finding in that it is seldom considered in the differential diagnosis of contrast-enhancing, demarcated sellar region masses. Granular cell tumors are benign and slow growing with no pronounced tendency for invasion or recurrence. Because of the indolent growth of granular cell tumors, the surgical goal of tumor decompression is a reasonable therapeutic approach.

Original languageEnglish (US)
Pages (from-to)567-573
Number of pages7
JournalMayo Clinic Proceedings
Volume78
Issue number5
StatePublished - May 1 2003

Fingerprint

Granular Cell Tumor
Visual Fields
Hemianopsia
Neoplasms
Decompression
Telephone
Medical Records
Blood Vessels
Headache
Disease Progression
Differential Diagnosis
Radiotherapy
Retrospective Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cohen-Gadol, A. A., Pichelmann, M. A., Link, M. J., Scheithauer, B. W., Krecke, K. N., Young, W. F., ... Giannini, C. (2003). Granular cell tumor of the sellar and suprasellar region: Clinicopathologic study of 11 cases and literature review. Mayo Clinic Proceedings, 78(5), 567-573.

Granular cell tumor of the sellar and suprasellar region : Clinicopathologic study of 11 cases and literature review. / Cohen-Gadol, Aaron A.; Pichelmann, Mark A.; Link, Michael J.; Scheithauer, Bernd W.; Krecke, Karl N.; Young, William Francis; Hardy, Jules; Giannini, Caterina.

In: Mayo Clinic Proceedings, Vol. 78, No. 5, 01.05.2003, p. 567-573.

Research output: Contribution to journalArticle

Cohen-Gadol, AA, Pichelmann, MA, Link, MJ, Scheithauer, BW, Krecke, KN, Young, WF, Hardy, J & Giannini, C 2003, 'Granular cell tumor of the sellar and suprasellar region: Clinicopathologic study of 11 cases and literature review', Mayo Clinic Proceedings, vol. 78, no. 5, pp. 567-573.
Cohen-Gadol AA, Pichelmann MA, Link MJ, Scheithauer BW, Krecke KN, Young WF et al. Granular cell tumor of the sellar and suprasellar region: Clinicopathologic study of 11 cases and literature review. Mayo Clinic Proceedings. 2003 May 1;78(5):567-573.
Cohen-Gadol, Aaron A. ; Pichelmann, Mark A. ; Link, Michael J. ; Scheithauer, Bernd W. ; Krecke, Karl N. ; Young, William Francis ; Hardy, Jules ; Giannini, Caterina. / Granular cell tumor of the sellar and suprasellar region : Clinicopathologic study of 11 cases and literature review. In: Mayo Clinic Proceedings. 2003 ; Vol. 78, No. 5. pp. 567-573.
@article{0cf86c55d37e446f91fe677869c4d8c9,
title = "Granular cell tumor of the sellar and suprasellar region: Clinicopathologic study of 11 cases and literature review",
abstract = "Objective: To report a series of cases of surgically resected granular cell tumors in an attempt to better characterize their clinical presentation, imaging features, and treatment outcomes with attention to previously published literature. Patients and Methods: This is a retrospective study of 11 patients with granular cell tumors. Information obtained from patients' medical records was supplemented by direct physician and patient telephone contact. Results: The study group consisted of 9 women and 2 men, with a mean ± SD age of 50±15 years (range, 26-73 years). Seven patients were symptomatic, 3 of whom presented with visual complaints. Four patients presented primarily with endocrine dysfunction (2) or headaches (2). The duration of symptoms varied from 1 to 12 months (mean ± SD, 6.0±4.5 months). Formal visual field testing revealed bitemporal hemianopsia in 6 and a right-sided visual field deficit in 2. The tumor appeared as a welldefined, relatively homogeneously (6) or heterogeneously (1) enhancing suprasellar mass on contrast infusion. Tumor size varied from 1.5 to 6.0 cm (mean ± SD, 3.1±1.6 cm). At surgery, the mass was noted to be firm and vascular, and in at least 3 patients these features prevented gross total resection. Only 1 patient who had undergone biopsy of his lesion received adjuvant radiation therapy. Followup was obtained in all but 1 patient. Nine of these 10 patients are alive and are either free of disease or have had no disease progression. Follow-up in these 9 patients varied from 1 to 16 years (mean ± SD, 6.5±5.3 years). Conclusions: A granular cell tumor is generally a surprise finding in that it is seldom considered in the differential diagnosis of contrast-enhancing, demarcated sellar region masses. Granular cell tumors are benign and slow growing with no pronounced tendency for invasion or recurrence. Because of the indolent growth of granular cell tumors, the surgical goal of tumor decompression is a reasonable therapeutic approach.",
author = "Cohen-Gadol, {Aaron A.} and Pichelmann, {Mark A.} and Link, {Michael J.} and Scheithauer, {Bernd W.} and Krecke, {Karl N.} and Young, {William Francis} and Jules Hardy and Caterina Giannini",
year = "2003",
month = "5",
day = "1",
language = "English (US)",
volume = "78",
pages = "567--573",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "5",

}

TY - JOUR

T1 - Granular cell tumor of the sellar and suprasellar region

T2 - Clinicopathologic study of 11 cases and literature review

AU - Cohen-Gadol, Aaron A.

AU - Pichelmann, Mark A.

AU - Link, Michael J.

AU - Scheithauer, Bernd W.

AU - Krecke, Karl N.

AU - Young, William Francis

AU - Hardy, Jules

AU - Giannini, Caterina

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Objective: To report a series of cases of surgically resected granular cell tumors in an attempt to better characterize their clinical presentation, imaging features, and treatment outcomes with attention to previously published literature. Patients and Methods: This is a retrospective study of 11 patients with granular cell tumors. Information obtained from patients' medical records was supplemented by direct physician and patient telephone contact. Results: The study group consisted of 9 women and 2 men, with a mean ± SD age of 50±15 years (range, 26-73 years). Seven patients were symptomatic, 3 of whom presented with visual complaints. Four patients presented primarily with endocrine dysfunction (2) or headaches (2). The duration of symptoms varied from 1 to 12 months (mean ± SD, 6.0±4.5 months). Formal visual field testing revealed bitemporal hemianopsia in 6 and a right-sided visual field deficit in 2. The tumor appeared as a welldefined, relatively homogeneously (6) or heterogeneously (1) enhancing suprasellar mass on contrast infusion. Tumor size varied from 1.5 to 6.0 cm (mean ± SD, 3.1±1.6 cm). At surgery, the mass was noted to be firm and vascular, and in at least 3 patients these features prevented gross total resection. Only 1 patient who had undergone biopsy of his lesion received adjuvant radiation therapy. Followup was obtained in all but 1 patient. Nine of these 10 patients are alive and are either free of disease or have had no disease progression. Follow-up in these 9 patients varied from 1 to 16 years (mean ± SD, 6.5±5.3 years). Conclusions: A granular cell tumor is generally a surprise finding in that it is seldom considered in the differential diagnosis of contrast-enhancing, demarcated sellar region masses. Granular cell tumors are benign and slow growing with no pronounced tendency for invasion or recurrence. Because of the indolent growth of granular cell tumors, the surgical goal of tumor decompression is a reasonable therapeutic approach.

AB - Objective: To report a series of cases of surgically resected granular cell tumors in an attempt to better characterize their clinical presentation, imaging features, and treatment outcomes with attention to previously published literature. Patients and Methods: This is a retrospective study of 11 patients with granular cell tumors. Information obtained from patients' medical records was supplemented by direct physician and patient telephone contact. Results: The study group consisted of 9 women and 2 men, with a mean ± SD age of 50±15 years (range, 26-73 years). Seven patients were symptomatic, 3 of whom presented with visual complaints. Four patients presented primarily with endocrine dysfunction (2) or headaches (2). The duration of symptoms varied from 1 to 12 months (mean ± SD, 6.0±4.5 months). Formal visual field testing revealed bitemporal hemianopsia in 6 and a right-sided visual field deficit in 2. The tumor appeared as a welldefined, relatively homogeneously (6) or heterogeneously (1) enhancing suprasellar mass on contrast infusion. Tumor size varied from 1.5 to 6.0 cm (mean ± SD, 3.1±1.6 cm). At surgery, the mass was noted to be firm and vascular, and in at least 3 patients these features prevented gross total resection. Only 1 patient who had undergone biopsy of his lesion received adjuvant radiation therapy. Followup was obtained in all but 1 patient. Nine of these 10 patients are alive and are either free of disease or have had no disease progression. Follow-up in these 9 patients varied from 1 to 16 years (mean ± SD, 6.5±5.3 years). Conclusions: A granular cell tumor is generally a surprise finding in that it is seldom considered in the differential diagnosis of contrast-enhancing, demarcated sellar region masses. Granular cell tumors are benign and slow growing with no pronounced tendency for invasion or recurrence. Because of the indolent growth of granular cell tumors, the surgical goal of tumor decompression is a reasonable therapeutic approach.

UR - http://www.scopus.com/inward/record.url?scp=0038745656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038745656&partnerID=8YFLogxK

M3 - Article

VL - 78

SP - 567

EP - 573

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 5

ER -